Shapiro Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Shapiro Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,592,531	Closed	-$85.7M	–	83
2022 Q1	$85.7M	Sell	4,592,531 -1,355,300	-23%	-$24.4M	1.8%	27
2021 Q4	$127M	Sell	5,947,831 -767,800	-11%	-$15.1M	2.32%	18
2021 Q3	$124M	Buy	6,715,631 +1,149,050	+21%	+$23.1M	2.32%	20
2021 Q2	$119M	Buy	5,566,581 +1,457,515	+35%	+$29.6M	2.07%	23
2021 Q1	$79.3M	Buy	+4,109,066	New	+$72.4M	1.44%	28

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Shapiro Capital Management's OCDX Position: Q2 2022 in Review

Shapiro Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 4,592,531 shares — an estimated $85.7M sold.

Shapiro Capital Management first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $127M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Shapiro Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Shapiro Capital Management sold 4,592,531 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $85.7M.
Shapiro Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Shapiro Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $127M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Shapiro Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.